• Home
  • News
    • Editorial
    • MD(e)B(unker)
    • Related Researches
      • Di Bella's Foundation
      • 1960-1969
      • 1970-1979
      • 1980-1989
      • 1990-1999
      • 2000-2009
      • 2010-2019
      • 2020-2029
    • Science news
    • Scientific Documentation
  • About us...
    • Biography
    • Bibliography
  • The Method
    • Di Bella's Method!
    • 1998 Trial!
  • Media
    • Video Publications
    • News-PapersNews-Papers
      • Press
    • TestimonialTestimonial
      • Testimonies
    • Video GalleryVideo Gallery
      • Congresses
      • Video Testimonies
      • TV & C.
  • Case History
    • Medical reports
      • Lung
      • Lymphomas
        • Non-Hodgkin Lymphomas
        • Hodgkin Lymphomas
      • Mediastinum
      • Mesothelioma
      • Myeloma
      • Pancreas
      • Scientific Publications
  • F.A.Q.
  • Useful Links
    • User Side
      • Vademecum
    • CouponChief - Resources for Cancer Patients
  • Contact Us
Home page   News   Related Researches  
Title Created Date
Melatonin resynchronizes dysregulated circadian rhythm circuitry in human prostate cancer cells 12 December 2014
Melatonin: a multitasking molecule 12 December 2014
Tumor microenvironment: the promising target for tumor therapy 09 December 2014
Melatonin, a promising role in taxane-related neuropathy 09 December 2014
Contrast enhanced multi-detector CT and MR findings of a well-differentiated pancreatic vipoma 08 December 2014
Inhibitory effects of melatonin on sulfatase and 17beta-hydroxysteroid dehydrogenase activity and expression in glioma cells 05 December 2014
Vitamin A, cancer treatment and prevention: the new role of cellular retinol binding proteins 01 December 2014
A role for acyclic retinoid in the chemoprevention of hepatocellular carcinoma: therapeutic strategy targeting phosphorylated retinoid X receptor-α 01 December 2014
Signal transduction of receptor-mediated antiproliferative action of melatonin on human prostate epithelial cells involves dual activation of Gα(s) and Gα(q) proteins 26 November 2014
Differentiated expression of somatostatin receptor subtypes in experimental models and clinical neuroblastoma 24 November 2014
Display # 

Page 151 of 172

  • Start
  • Prev
  • 146
  • 147
  • 148
  • 149
  • 150
  • 151
  • 152
  • 153
  • 154
  • 155
  • Next
  • End

Search

Follow us...

Latest

  • Melatonin: An Anti-Tumor Agent in Hormone-Dependent Cancers
  • Updated perspectives on vitamin D deficiency, screening, supplementation and clinical guidance
  • Melatonin: an inhibitor of breast cancer
  • All-trans retinoic acid suppresses CD8+ T-cell terminal exhaustion and potentiates anti-PD-1 therapy in glioblastoma
  • Retinoid-induced suppression of squamous cell differentiation in human oral squamous cell carcinoma xenografts (line 1483) in athymic nude mice
  • Effect of oral melatonin on sleep quality, fatigue, and caregiver sleep perception in patients with head and neck cancer: A randomized double-blind placebo-controlled trial
  • Mechanisms Underlying Tumor Suppressive Properties of Melatonin
  • Vitamin D supplementation is associated with reduced risk of hepatobiliary malignancy in patients with primary sclerosing cholangitis
  • Growth-inhibitory activity of melatonin on human androgen-independent DU 145 prostate cancer cells
  • A case control study to determine the frequency of vitamin d deficiency in carcinoma breast in females of local population of Rawalpindi and Islamabad area
  • In vitro and in vivo antitumor activity of melatonin receptor agonists
  • Proteoformics-driven new concept of human growth hormone in clinical endocrinology
  • The role of melatonin in colorectal cancer treatment: a comprehensive review
  • The Role of Melatonin in Colorectal Cancer
  • Ameliorative effects of melatonin on radiotherapy-induced apoptotic and inflammatory responses in rat parotid gland
  • The role of melatonin in immuno-enhancement: potential application in cancer
  • Circulating neuroendocrine markers in patients with prostate carcinoma
  • Somatostatin and the treatment of cancer

Most Read

  • The Di Bella Method (DBM)
  • About melatonin - 1996
  • All-trans-retinoic acid and cancer
  • Biography
  • Chronic Lymphocytic Leukemia: 4 patients, long-lasting remission
  • Somatostatin in oncology, the overlooked evidences
  • The Di Bella Method Increases by the 30% the survival rate for Pancreas tumors and for this reason should be proposed as first line therapy for this type of cancer
  • Treatment of Low-grade Non-Hodgkin’s Lymphomas at Advanced Stage
  • How effective is chemo therapy?
  • Complete objective response to biological therapy of plurifocal breast carcinoma
  • Bibliography
  • Large B-cells Non-Hodgkin's Lymphoma, Stage IV-AE: a Case Report
  • Non-Hodgkin's Lymphoma, Stage III-B-E: a Case Report
  • Vademecum
  • Frequently Asked Questions
  • Declaration recommends eliminate the use of Impact factor for research evaluation
  • Non–Small-Cell Lung Cancer Patients with Low Performance Status: study on 28 patients
  • Breast cancer: study on 122 cases. The Di Bella Method (DBM) improved survival, objective response and performance status in a retrospective observational clinical study on 122 cases of breast cancer